Zhejiang Gongdong Medical Technology Co.,Ltd.
SSE:605369.SS
27.39 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 264.476 | 279.177 | 282.308 | 279.885 | 271.918 | 262.403 | 254.474 | 232.018 | 226.189 | 289.032 | 380.685 | 451.218 | 347.749 | 347.518 | 270.696 | 314.005 | 262.035 | 240.793 | 251.52 | 234.955 | 102.384 | 154.709 | 145.956 | 138.962 | 126.158 |
| Cost of Revenue
| 178.781 | 192.3 | 187.4 | 190.935 | 181.808 | 172.939 | 172.946 | 163.466 | 147.341 | 193.73 | 234.768 | 268.973 | 191.089 | 218.984 | 146.07 | 168.359 | 131.114 | 116.939 | 127.339 | 119.292 | 55.221 | 87.215 | 79.07 | 75.177 | 70.543 |
| Gross Profit
| 85.695 | 86.876 | 94.908 | 88.95 | 90.111 | 89.464 | 81.529 | 68.552 | 78.848 | 95.302 | 145.918 | 182.245 | 156.66 | 128.533 | 124.626 | 145.646 | 130.921 | 123.854 | 124.181 | 115.663 | 47.163 | 67.493 | 66.886 | 63.785 | 55.614 |
| Gross Profit Ratio
| 0.324 | 0.311 | 0.336 | 0.318 | 0.331 | 0.341 | 0.32 | 0.295 | 0.349 | 0.33 | 0.383 | 0.404 | 0.45 | 0.37 | 0.46 | 0.464 | 0.5 | 0.514 | 0.494 | 0.492 | 0.461 | 0.436 | 0.458 | 0.459 | 0.441 |
| Reseach & Development Expenses
| 10.633 | 16.276 | 13.094 | 11.702 | 11.135 | 12.346 | 9.928 | 9.249 | 16.292 | 12.895 | 18.704 | 27.012 | 13.734 | 22.211 | 9.943 | 15.037 | 11.098 | 14.075 | 9.716 | 8.574 | 4.615 | 6.287 | 5.808 | 6.007 | 5.12 |
| General & Administrative Expenses
| 26.285 | -37.85 | 49.971 | -9.662 | 21.861 | -35.685 | 48.676 | -6.932 | 19.586 | -16.141 | 46.475 | -8.018 | 17.854 | -28.412 | 42.52 | -8.742 | 16.932 | -24.182 | 14.221 | 13.567 | 8.96 | -18.946 | 8.719 | 11.572 | 9.826 |
| Selling & Marketing Expenses
| 9.277 | -0.606 | 18.933 | 10.891 | 13.135 | 17.002 | 19.691 | 15.604 | 12.85 | 17.358 | 14.777 | 17.868 | 13.361 | 24.934 | 7.206 | 6.369 | 18.769 | 15.774 | 15.051 | 13.041 | 7.461 | 11.638 | 12.739 | 12.285 | 11.09 |
| SG&A
| 35.562 | -38.456 | 31.395 | 30.492 | 34.996 | -18.683 | 68.366 | 8.672 | 32.436 | 1.217 | 61.252 | 9.85 | 31.215 | -3.479 | 49.726 | -2.373 | 35.701 | -8.407 | 29.272 | 26.608 | 16.421 | -7.308 | 21.458 | 24.424 | 21.15 |
| Other Expenses
| 12.036 | 75.877 | 0 | 0.082 | -0.073 | -0.399 | -1.19 | 1.021 | -4.782 | 62.258 | -23.791 | 26.813 | -0.271 | -1.283 | -0.108 | 2.5 | -0.101 | -1.352 | 1.235 | -0.426 | -0.302 | 0.292 | -0.374 | 0 | 0 |
| Operating Expenses
| 58.231 | 53.698 | 43.625 | 42.194 | 47.297 | 58.054 | 53.784 | 46.507 | 43.946 | 76.37 | 56.165 | 63.675 | 44.679 | 60.651 | 37.627 | 38.403 | 48.545 | 37.85 | 40.86 | 34.166 | 21.224 | 30.895 | 27.987 | 31.393 | 27.615 |
| Operating Income
| 27.464 | 33.179 | 51.284 | 46.756 | 52.139 | 20.872 | 30.446 | 33.549 | 34.854 | 18.174 | 40.417 | 134.383 | 109.559 | 70.764 | 87.484 | 109.068 | 92.407 | 79.242 | 79.355 | 77.925 | 26.74 | 36.712 | 39.414 | 32.136 | 28.884 |
| Operating Income Ratio
| 0.104 | 0.119 | 0.182 | 0.167 | 0.192 | 0.08 | 0.12 | 0.145 | 0.154 | 0.063 | 0.106 | 0.298 | 0.315 | 0.204 | 0.323 | 0.347 | 0.353 | 0.329 | 0.316 | 0.332 | 0.261 | 0.237 | 0.27 | 0.231 | 0.229 |
| Total Other Income Expenses Net
| -0.524 | -2.553 | -2.453 | 11.87 | -0.073 | -0.399 | -0.13 | -0.039 | 0.072 | -0.531 | -0.113 | -0.455 | -0.069 | -1.283 | -0.108 | 2.5 | -0.101 | -1.352 | 1.235 | -0.426 | -0.302 | 0.292 | -0.374 | -0.076 | -0.183 |
| Income Before Tax
| 26.94 | 30.626 | 48.83 | 58.626 | 52.066 | 20.474 | 30.316 | 33.51 | 34.926 | 17.643 | 109.606 | 133.927 | 109.49 | 69.481 | 87.376 | 111.569 | 92.306 | 77.89 | 80.59 | 77.499 | 26.438 | 37.004 | 39.04 | 32.3 | 27.954 |
| Income Before Tax Ratio
| 0.102 | 0.11 | 0.173 | 0.209 | 0.191 | 0.078 | 0.119 | 0.144 | 0.154 | 0.061 | 0.288 | 0.297 | 0.315 | 0.2 | 0.323 | 0.355 | 0.352 | 0.323 | 0.32 | 0.33 | 0.258 | 0.239 | 0.267 | 0.232 | 0.222 |
| Income Tax Expense
| -0.322 | 0.505 | 4.895 | 4.874 | 6.957 | -0.402 | 3.022 | 1.467 | 6.013 | 0.044 | 11.706 | 18.432 | 14.435 | 10.444 | 12.482 | 13.875 | 12.943 | 10.98 | 11.158 | 11.851 | 2.547 | 5.435 | 5.285 | 4.383 | 3.821 |
| Net Income
| 27.412 | 30.236 | 46.103 | 50.185 | 45.109 | 20.876 | 27.294 | 32.042 | 28.913 | 17.6 | 97.9 | 115.495 | 95.054 | 59.037 | 74.894 | 97.694 | 79.363 | 66.91 | 69.432 | 65.647 | 23.891 | 31.57 | 33.755 | 27.916 | 24.133 |
| Net Income Ratio
| 0.104 | 0.108 | 0.163 | 0.179 | 0.166 | 0.08 | 0.107 | 0.138 | 0.128 | 0.061 | 0.257 | 0.256 | 0.273 | 0.17 | 0.277 | 0.311 | 0.303 | 0.278 | 0.276 | 0.279 | 0.233 | 0.204 | 0.231 | 0.201 | 0.191 |
| EPS
| 0.17 | 0.19 | 0.29 | 0.32 | 0.4 | 0.18 | 0.24 | 0.29 | 0.26 | 0.16 | 0.88 | 1.03 | 0.85 | 0.38 | 0.93 | 1.22 | 0.71 | 0.8 | 0.83 | 0.79 | 0.29 | 0.38 | 0.41 | 0.34 | 0.29 |
| EPS Diluted
| 0.17 | 0.19 | 0.29 | 0.32 | 0.4 | 0.18 | 0.24 | 0.29 | 0.26 | 0.16 | 0.87 | 1.02 | 0.84 | 0.38 | 0.93 | 1.22 | 0.71 | 0.8 | 0.83 | 0.79 | 0.29 | 0.38 | 0.41 | 0.34 | 0.29 |
| EBITDA
| 28.966 | 31.82 | 51.909 | 81.103 | 68.16 | 35.981 | 54.643 | 52.042 | 53.466 | 29.478 | 80.59 | 133.937 | 118.282 | 75.322 | 93.188 | 116.659 | 97.396 | 77.89 | 80.59 | 81.497 | 31.107 | 40.44 | 42.098 | 35.338 | 32.086 |
| EBITDA Ratio
| 0.11 | 0.114 | 0.184 | 0.29 | 0.251 | 0.137 | 0.215 | 0.224 | 0.236 | 0.102 | 0.212 | 0.297 | 0.34 | 0.217 | 0.344 | 0.372 | 0.372 | 0.323 | 0.32 | 0.347 | 0.304 | 0.261 | 0.288 | 0.254 | 0.254 |